Figure 6.
Distribution of selected feature values among patients grouped by disease progression at the 12th month. Group A: Disease progression at 12th month; Group B: Without disease progression at 12th month. GLSZM, gray level size zone matrix; GLRLM, gray level run length matrix; GLDM, gray level dependence matrix; IQR, interquartile range.